R1 RCM (NASDAQ:RCM) Shares Down 4% on Analyst Downgrade
From MarketBeat:
R1 RCM Inc. (NASDAQ:RCM) saw a 4% decrease in share price after KeyCorp lowered its price target from $18.00 to $13.00, maintaining an overweight rating on the stock. 2,195,723 shares traded hands during mid-day trading, falling 18% from the average session volume. Other analysts also adjusted their ratings, with a consensus target price of $18.00.
A number of hedge funds and institutional investors have added to or reduced their stakes in R1 RCM, with 61.10% of the company’s stock owned by institutional investors and hedge funds.
R1 RCM Inc provides technology-driven solutions that transform patient experience and financial performance of healthcare providers, offering end-to-end revenue cycle management services.
The company has a debt-to-equity ratio of 0.60, a current ratio of 1.89 and a quick ratio of 1.89, with a 50-day moving average of $10.68 and a 200-day moving average of $14.14.
Read more: R1 RCM (NASDAQ:RCM) Shares Down 4% on Analyst Downgrade